Evidence suggests that dysregulation of epidermal growth factor receptor (EGFR) signaling may contribute to cancer cell proliferation, increase tumor vascularization and enhance metastasis [12] and overexpression of EGFR is associated with castration-resistant and high-risk prostate cancer, as well as prostate cancer bone metastasis [13]. The gene discussed is EGFR; the disease is prostate carcinoma.